SKAN AG / CH0013396012

Ad hoc announcement pursuant to Art. 53 LR
  Metronik, headquartered in Slovenia, is a leading provider of digitalization and automation systems and solutions for the life sciences sector; the company offers an interesting addition to the SKAN Group's range of services for customers. The company generated sales of over EUR 25 million in fiscal year 2024. Integration into the Services & Consumables segment as of the closing date; strengthening of segment sales and margin in line with strategy. Positive contribution to EPS is already expected in fiscal year 2025. SKAN Group will acquire 76% of Metronik; the remaining 24% will be held by the existing management, which will continue to lead the company. Closing of the acquisition expected in the third quarter of 2025.
Allschwil, 23. May 2025 – The SKAN Group AG, world market leader for high-quality isolator systems for aseptic production processes in the (bio-) pharmaceutical industry, has signed an agreement to acquire a majority stake in Metronik d.o.o. Metronik d.o.o. is a leading provider of software solutions for manufacturing operations management, digital transformation, automation as well as control of production, energy and clean media related processes with a strong focus on the regulated life sciences sector. Metronik's modular, proprietary and web-based software offers solutions for manufacturing execution systems (MES), recipe management, process data management, energy management, environmental management and operational excellence, among other things. In addition, Metronik has extensive expertise in process automation, IoT integration and facility management. Thomas Huber, CEO of the SKAN Group, explains: “The integration of Metronik is another milestone in the digitalization of SKAN's offering. Seamless integration into our customers' production processes enables us to increase their efficiency along the entire value chain.” Aleksander Temeljotov, Managing Director of Metronik, adds: “With the SKAN Group, we have found an ideal succession solution that will continue to motivate Metronik's management and give both companies' growth stories an additional boost. We are convinced that Metronik's process software solutions will ideally complement SKAN's service offering and accelerate its digitalization initiatives.”
35 years of market experience Founded in 1990 and headquartered in Ljubljana, Metronik today employs more than 160 highly qualified people including 140 software development, digitalization, automation, and engineering specialists. Following strong growth in recent years, the company generated sales of over EUR 25 million in fiscal year 2024. Metronik will continue to operate as an independent company and will be managed by the existing management team. Within the SKAN Group, Metronik will be integrated into the Services & Consumables segment as of the closing date, strengthening the segment's sales and margin profile. The SKAN Group will acquire 76% of Metronik; the remaining 24% will remain with management. The purchase price will be fully financed through bank loans. The parties have agreed not to disclose the financial details. Subject to the anticipated regulatory approvals, the closing is expected in the third quarter of 2025.
Strategic fit with the SKAN Group The acquisition strengthens the services and consumables segment by expanding the range to include software and digital integration services, in line with the SKAN Group's strategy. It also supports other strategic objectives of the SKAN Group, particularly with regard to the strategic cornerstone “Accelerate digital transformation”. In addition to expanding its automation expertise and range of services with a focus on MES, Metronik's solutions and expertise create the conditions for digital workflow management that enable initiatives such as “One Button Release” and paperless pharmaceutical production. Furthermore, the solutions in the areas of energy management, environmental management and facility management are also highly relevant for the SKAN Group from an ESG perspective.
  Conference call and audio webcast: Thomas Huber, CEO, and Burim Maraj, CFO, will present the key aspects of the transaction in a conference call and audio webcast today and will be available to answer questions afterwards. The conference call and audio webcast in English will take place as follows: 23 May 2025 3.30 to approx. 4.30 pm To participate in the conference call, you may register via this link. You will receive a confirmation email with individual dial-in information. Participants in the conference call can follow the presentation here (please mute the sound in your browser). To take part in the Q&A session, please register for the conference call. The presentation will also be available as a audio webcast. Please use this link to access the audiowebcast. If you have any questions, please contact ir@skan.com, +41 79 703 87 28.   Contacts: Thomas Balmer, ir@skan.com, +41 79 703 87 28
Alexandre Müller, ir@skan.com, +41 79 635 64 13
Financial calendar:

19 August 2025	Publication Half-Year Results 2025
24 March 2026	Publication Annual Results 2025
7 May 2026	Annual General Meeting 2026

  SKAN – together always one step ahead SKAN is a pioneer in the field of aseptic and aseptic-toxic manufacturing processes for the (bio)pharmaceutical industry. The company is the market and technology leader for high-quality, process-critical isolator systems for filling drugs according to strict sterility standards. In addition, the company offers its customers process support, services and consumables. Innovative solutions and an efficient life-cycle support organisation make SKAN an important partner for the pharmaceutical and biotech industry, CMOs (Contract Manufacturing Organisations) and research laboratories worldwide. Founded in 1968, SKAN today employs approximately 1500 people. More than half of them work at the Allschwil headquarters in the Life Sciences Hub of the Basel region. The other employees are located among the subsidiaries in Switzerland, Germany, Belgium, Japan, the USA and Brazil.